Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-01-10
1997-01-07
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
564174, 564177, A61K 31165, C07C23308
Patent
active
055917763
ABSTRACT:
Rolipram-based PDE IV inhibitors containing phenyl- or benzyl-substituted moieties of the formula: ##STR1## wherein X.sub.1 and X.sub.2 may be the same or different and each is O or S;
REFERENCES:
patent: 3135753 (1964-06-01), Hitchings
patent: 4925847 (1990-05-01), Hofer
CA116:255335, 1992.
CA114:246982, 1990.
CA103:37354, 1985.
CA92:6207, 1977.
CA88:51054, 1977.
Chem. Abstracts, vol. 82 (19), May 12, 1975, Abstract #49027b.
Chem. Abstracts, vol. 75 (7), Aug. 16, 1971, Abstract #125358x.
Tetrahedron Letters, vol. 23 (No. 21), 1982, pp. 2203-2204.
Chem. Abstracts, vol. 85 (1) Jul. 5, 1976, Abstract #5692S.
Chem. Abstracts. vol. 84 (25) Jun. 21, 1976, Abstract #180,299v.
Chem. Abstracts. vol. 86 (7) Feb. 14, 1977, Abstract #43,746r.
"Could Isoenzyme-selective phosphodiesterase Inhibitiors render bronchodilator therapy, redundant in the treatment of bronchial asthma?". Mark A. Glembycz, Biochemical Pharmacology. 1992, vol. 43. No. 10, pp. 2041-2051.
"Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle", Paul J. Silver, Linda T. Hamel, Mark II, Perrone, Ross G. Bently, Cynthia R. Bushover and Dale B. Evans, European Journal of Phamacology, 150 )1988) 85-94, Elsvier.
"The pharmacology and therapeutic use of theophylline", Miles Weinberger, M. D., The Journal of Allergy and Clincial Immamology, vol. 73, No. 5, Part 1, 525-544.
"Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme", W. Joseph Thompson, Wesley L. Terasaki, Paul M. Epstein, Samuel J. Strada, Advances in Cyclic Nucleotide Research, vol. 10, 1979, 69-92.
"Identification, characterization and functional role of phosphodiesterase isozymes in lamen airway smooth muscle", Theodore J. Torphy, Bradley J. Undem. Lenora B. Cleslinski, Mark A. Luttmann, Martin L. Reeves and Douglas W. P. Llay, The Journal of Pharmacology and Experimental Therapeutics, 1993, vol. 265, No. 3, 1213-1223.
"The PDE IV family of calcium-independent phosphodiesterase enzymes", John A. Lowe III and John B. Cheng, Drugs of the Future 1992, 17(9): 799-807.
"Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes", C. David Nicholson, R. A. John Ciulliss and Mohammed Shahid, 1991, Elsevier Science Publishers Ltd. (UK), TIPS 12:19-27.
"Phosphodlisterase inhibitors: new opportunities for the treatment of asthma", Theodore J. Torphy, Bradley J. Undem. Thorax 1991: 46:512-523.
"Novel phosphodiesterase inhibitors for the therapy of asthma", Theodore J. Torphy, George P. Livi and Siegfried B. Christensen, DN&P 6(4), May 1993 203-214.
Cavalla David J.
Chasin Mark
Dolby Lloyd J.
Euro-Celtique S.A.
Gupta Yogendra N.
LandOfFree
Pheynl or benzyl-substituted rolipram-based compounds for and me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pheynl or benzyl-substituted rolipram-based compounds for and me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pheynl or benzyl-substituted rolipram-based compounds for and me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764757